Resverlogix

  • Home
  • Corporate Profile
    • Overview
    • History
    • Mission and Values
    • Senior Management
    • Board of Directors
    • Clinical Advisory Board
    • Clinical Steering Committee
  • Product Development
    • Overview
    • Cardiovascular Disease
      • Atherosclerosis
      • ApoA-I
    • Technology Platform
      • NexVas™ Animation
      • NexVas™ Plaque Regression
        • Lead Drug RVX-208
      • Autoimmune Drug Development Program
      • NexVas™ Alzheimer's Disease
    • ReVas™ Program
    • Clinical Trials
      • Completed Clinical Trials
    • Product Pipeline
    • Glossary
  • Partnering
    • Overview
    • Opportunities
  • Investors
    • Overview
    • Stock Info
    • Investor Documents
    • Analyst Coverage
    • FAQs
    • Investor Contact
  • Media
    • Overview
    • Press Releases
    • Fact Sheets
    • Events
    • Image Library
    • Awards & Recognition
    • Media Contact
  • Careers
    • Overview
    • Benefits
    • Current Opportunities
  • Contact Us
    • Request to be contacted
Investors
  • Overview
  • Stock Info
  • Investor Documents
  • Analyst Coverage
  • FAQs
  • Investor Contact

Investor Documents

The following documents require Adobe Acrobat Reader click to download.

Download PDFOctober 31, 2011 Financial Statement
Download PDFOctober 31, 2011 MD&A
Download PDF2011 AIF
Download PDFJuly 31, 2011 Financial Statements
Download PDFJuly 31, 2011 MD&A
Download PDFYear End April 30, 2011 Financial Statement
Download PDFYear End April 30, 2011 MD&A
Download PDFJanuary 31, 2011 MD&A
Download PDFJanuary 31, 2011 Financial Statements
Download PDFOctober 31, 2010 Financial Statement
Download PDFOctober 31, 2010 MD&A
Download PDF2010 Annual Report
Download PDFJuly 31, 2010 Financial Statements
Download PDFJuly 31, 2010 MD&A
Download PDF2010 AIF
Download PDFYear End April 30, 2010 MD&A
Download PDFYear End April 30, 2010 Financial Statement
Download PDFJanuary 31, 2010 Financial Statement
Download PDFJanuary 31, 2010 MD&A
Tweet

Page Tools

Email Print SmallMediumLargeChoose Font Size

Related Links

FAQs
Press Releases
Glossary

Stock Quote

TSX:RVX Price: 1.92
  Change: 0.08

NEXVAS™ Animation

NexVas™ Animation

Annual Report

2011 Annual Report

Home | FAQ | Glossary | Sitemap | Contact Us
© 2012 Resverlogix Corp. | Legal Notice | handcrafted by nonfiction

This page was last updated on: January 25, 2012